Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Parenteral versus enteral iron in young patients with inflammatory bowel disease
NL-OMON27310Completed
- Sponsor
- Atrium Medisch Centrum Parkstad
- Start
- Jun 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label trial of ferric carboxymaltose and ferrous fumarate in iron deficiency anemia (IDA) and inflammatory bowel disease (IBD) (2 arms), sponsored by Atrium Medisch Centrum Parkstad. Started Jun 2015; status: completed.
02
Drugs
ferric carboxymaltoseferrous fumarate
03
Conditions
iron deficiency anemia (IDA)inflammatory bowel disease (IBD)
Beyond the preview
Go deeper on NL-OMON27310.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON27310.